Preferred Label : Histiocytosis-lymphadenopathy plus syndrome;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Histiocytosis with joint contractures and sensorineural deafness; SHML; Sinus histiocytosis and massive lymphadenopathy; PHID; H syndrome; Faisalabad histiocytosis; Hyperpigmentation, cutaneous, with hypertrichosis, hepatosplenomegaly, heart anomalies,
and hypogonadism with or without hearing loss; HJCD; Histiocytosis and lymphadenopathy with or without cutaneous, cardiac, and/or endocrine
features, joint contractures, and/or deafness; Pigmented hypertrichosis with insulin-dependent diabetes mellitus; Rosai-dorfman disease, familial;
Description : The histiocytosis-lymphadenopathy plus syndrome comprises features of 4 histiocytic
disorders previously thought to be distinct: Faisalabad histiocytosis (FHC), sinus
histiocytosis with massive lymphadenopathy (SHML), H syndrome, and pigmented hypertrichosis
with insulin-dependent diabetes mellitus syndrome (PHID). FHC described an autosomal
recessive disease involving joint deformities, sensorineural hearing loss, and subsequent
development of generalized lymphadenopathy and swellings in the eyelids that contain
histiocytes (summary by Morgan et al., 2010).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the solute carrier family 29 (nucleoside transporter), member
3 gene (SLC29A3, 612373.0001);
Laboratory abnormalities : Elevated inflammatory markers;
Prefixed ID : #602782;
Origin ID : 602782;
UMLS CUI : C1864445;
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)